GlassScriptPhysician profile
Brian T Briscoe
NPI 1912045212
$6,502.52
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $509 · 2020: $159 · 2022: $5,297 · 2023: $538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $500 · Food and Beverage: $38.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $500.00 |
| Food and Beverage | $38.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $5,751.07 | 2022-2023 | Dyanavel Xr, Quillichew Er, Quillivant |
| Allergan, INC. | $126.96 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $92.44 | 2019-2020 | |
| Lundbeck LLC | $76.62 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $72.98 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $70.51 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $67.19 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $35.44 | 2019 | |
| Bausch Health US, LLC | $34.69 | 2019 | |
| Ironshore Pharmaceuticals INC. | $30.24 | 2019-2020 | |
| Neuronetics, INC. | $29.89 | 2019 | |
| Adlon Therapeutics L.P. | $24.66 | 2020 | |
| Owp Pharmaceuticals, INC. | $17.97 | 2019 | |
| Alkermes, INC. | $17.94 | 2022 | |
| Axsome Therapeutics, INC. | $13.90 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $13.81 | 2019 | |
| Shire North American Group INC | $13.54 | 2019 | |
| Abbvie INC. | $12.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Briscoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.